Report Code: CMI50328

Published Date: June 2024

Pages: 320+

Category: India

Reports Description

India Peritoneal Dialysis Market was valued at USD 52.6 Million in 2024 and is expected to reach USD 145.2 Million by 2033, at a CAGR of 9.1% during the forecast period 2024 – 2033.

Peritoneal dialysis (PD) is a way of removing waste and surplus fluids from the body when the kidneys are unable to do so properly. It is a type of dialysis that uses the peritoneum, a membrane that lines the abdominal cavity, as a natural filter.

India Peritoneal Dialysis Market: Growth Factors

Increasing prevalence of end-stage renal disease

The increasing prevalence of end-stage renal disease (ESRD) in India has been a significant driver for the growth of the peritoneal dialysis market in the country. With a rising incidence of conditions such as diabetes and hypertension, which are leading causes of ESRD, the demand for effective renal replacement therapies has surged.

Peritoneal dialysis offers several advantages over haemodialysis, including lower cost, greater flexibility, and the potential for home-based treatment, which is particularly appealing in a country like India with its vast geographic spread and diverse population.

Furthermore, peritoneal dialysis does not require highly specialized infrastructure and can be administered with relatively simple equipment, making it more accessible, especially in rural and underserved areas where access to healthcare facilities may be limited.

As awareness about the benefits of peritoneal dialysis grows among both patients and healthcare providers, coupled with government initiatives to improve renal care infrastructure and increase access to dialysis services, the market for peritoneal dialysis is expected to continue expanding rapidly in India.

The approximate prevalence of CKD is 800 per million population (pmp), and the incidence of end-stage renal disease (ESRD) is 150-200 pmp.

Increasing demand for home dialysis treatment

The growing demand for home dialysis treatment is a significant driver propelling the expansion of the peritoneal dialysis market in India. Home dialysis, particularly peritoneal dialysis, offers numerous advantages over traditional centre-based haemodialysis, making it an appealing option for patients and healthcare providers alike.

Peritoneal dialysis allows patients to undergo treatment in the comfort of their own homes, offering greater flexibility, convenience, and independence compared to frequent visits to dialysis centres.

With India’s vast geographical expanse and varied healthcare infrastructure, home-based treatments alleviate the burden of travel and reduce the strain on already overstretched healthcare facilities, particularly in rural and remote areas where access to specialized medical care may be limited.

Moreover, the COVID-19 pandemic has underscored the importance of minimizing exposure to crowded healthcare settings, further fuelling the shift towards home-based dialysis solutions.

Additionally, peritoneal dialysis typically requires less complex equipment and infrastructure compared to haemodialysis, making it a more cost-effective option for both patients and healthcare systems in resource-constrained settings like India.

As awareness of the benefits of home dialysis grows and technology advances to improve the ease and safety of self-administered treatments, the market for peritoneal dialysis in India is poised for continued expansion to meet the evolving needs of patients and healthcare providers.

India Peritoneal Dialysis Market: Restraints

High cost

The high cost presents a significant hurdle to the growth of the peritoneal dialysis (PD) market in India. The expenses associated with PD can be prohibitive for many patients in India, where a considerable portion of the population faces financial constraints.

The upfront costs of PD equipment, including catheters, bags, and dialysis solutions, coupled with ongoing expenses for supplies and medical consultations, pose a substantial financial burden for patients and their families.

Moreover, the lack of widespread health insurance coverage for dialysis treatment exacerbates the affordability issue, as patients are often required to bear the expenses out of pocket. The high cost of PD not only limits access to treatment but also contributes to suboptimal patient outcomes, as some individuals may forego or delay therapy due to financial constraints, leading to complications and worsening health conditions.

Addressing the cost barriers through initiatives such as government subsidies, insurance coverage expansion, and promoting the use of cost-effective PD modalities could help improve access to this vital treatment option for kidney disease patients in India.

India Peritoneal Dialysis Market: Opportunities

Increasing healthcare expenditure

Increasing healthcare expenditure in India is a pivotal driver propelling growth in the peritoneal dialysis market. As healthcare spending rises, more resources become available for advanced medical treatments, including renal replacement therapies like peritoneal dialysis.

Moreover, increased healthcare expenditure fosters technological advancements and innovation in medical devices and equipment, leading to the development of more efficient and cost-effective peritoneal dialysis solutions tailored to the Indian market’s needs.

Additionally, rising healthcare expenditure facilitates greater awareness and education about chronic kidney disease and its management options, including peritoneal dialysis, among both healthcare professionals and the general population, further driving market growth by boosting demand for these services.

Consequently, the synergy between escalating healthcare spending and the demand for effective renal care solutions like peritoneal dialysis underscores its substantial growth potential within the Indian healthcare landscape.

According to the Centre for Budget and Governance Accountability’s (CBGA) analysis of the Union Budget, the overall allocation1 in 2024-25 for the health sector stood at USD 100 million, which is a marginal increase of 2.6% from the previous budget estimates (BE) and a 14.2% increase from the revised estimates.

India Peritoneal Dialysis Market: Segmentation Analysis

India Peritoneal Dialysis market is segmented by type, product, and region.  Based on type, the market is classified into Continuous Ambulatory Peritoneal Dialysis (CAPD), and  Automated Peritoneal Dialysis (APD).

Continuous Ambulatory Peritoneal Dialysis dominated the market in 2023 with a market share of 70.3% and is expected to keep its dominance during the forecast period 2024-2033.  Continuous Ambulatory Peritoneal Dialysis (CAPD) has been a significant driver in shaping the peritoneal dialysis market in India.

CAPD offers several advantages over traditional haemodialysis, making it a preferred choice for many patients. Its simplicity and flexibility allow patients to perform dialysis at home without the need for expensive machinery or frequent visits to healthcare facilities.

Moreover, CAPD offers patients greater independence and improved quality of life by allowing them to maintain their daily routines and avoid the disruption of frequent hospital visits. Additionally, CAPD has a lower risk of complications such as infection and vascular access-related issues compared to haemodialysis, further contributing to its growing popularity.

As awareness about the benefits of CAPD increases and healthcare providers expand their peritoneal dialysis programs, the demand for CAPD is expected to continue driving growth in the Indian peritoneal dialysis market, providing more patients with access to effective renal replacement therapy.

Based on product, the market is classified into Devices (Cyclers/Machines), PD Solutions/Fluids, PD Sets, and Catheters. PD Solutions/Fluids dominated the market in 2023 with a market share of 49.9% and is expected to keep its dominance during the forecast period 2024-2033.

PD solutions/fluids play a crucial role in driving the peritoneal dialysis (PD) market in India by providing an effective and convenient treatment option for patients with end-stage renal disease (ESRD). These solutions, which are infused into the peritoneal cavity through a catheter, facilitate the removal of waste products and excess fluid from the body, mimicking the function of healthy kidneys.

In India, where access to healthcare services can be challenging, PD offers several advantages, including lower cost, greater flexibility, and the ability for patients to undergo treatment at home, reducing the need for frequent hospital visits.

The availability of a variety of PD solutions tailored to different patient needs further enhances the appeal of this therapy. As the prevalence of ESRD continues to rise in India due to factors such as an aging population and increasing incidence of diabetes and hypertension, the demand for PD solutions is expected to grow significantly.

Moreover, ongoing advancements in PD technology and the introduction of innovative formulations with improved biocompatibility and efficacy are likely to further propel market growth, making PD an increasingly vital component of renal care in India.

Report Scope

Feature of the Report Details
Market Size in 2024 USD 52.6 Million
Projected Market Size in 2033 USD 145.2 Million
Market Size in 2023 USD 51.3 Million
CAGR Growth Rate 9.1% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Type, Product and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Country Scope India
Buying Options Request tailored purchasing options to fulfil your requirements for research.

India Peritoneal Dialysis Market: Regional Analysis

By region, the Peritoneal Dialysis market is segmented into East India, West India, North India and South India. West India dominated the India Peritoneal Dialysis market in 2023 with a market share of 41.4% and is expected to keep its dominance during the forecast period 2024-2033.

The West India region plays a pivotal role in propelling the peritoneal dialysis market within India due to several key factors. Firstly, the region is characterized by a high prevalence of chronic kidney disease (CKD), a primary indication for peritoneal dialysis, attributed to lifestyle factors, genetic predispositions, and a rising geriatric population.

Furthermore, West India encompasses major metropolitan areas such as Mumbai, Pune, and Ahmedabad, which serve as hubs for healthcare infrastructure, including specialized nephrology centers and dialysis facilities.

Additionally, the West Indian region is home to a burgeoning medical tourism industry, drawing patients from across the country and abroad for affordable yet high-quality healthcare services, including peritoneal dialysis.

Consequently, the concentration of healthcare resources, coupled with a growing patient population and medical tourism influx, positions West India as a driving force in shaping the landscape and growth trajectory of the peritoneal dialysis market in India.

India Peritoneal Dialysis Market: Recent Developments

  • In October 2019, The Indian Union Ministry of Health and Family Welfare announced the establishment of a new set of guidelines for peritoneal dialysis services under the Pradhan Mantri National Dialysis Programme.
  • In May 2019, The Indian Union Ministry of Health and Family Welfare announced the plans to offer peritoneal dialysis facilities for patients suffering from kidney ailments under the Pradhan Mantri National Dialysis Programme (PMNDP).

List of the prominent players in the India Peritoneal Dialysis Market:

  • Fresenius Medical Care
  • Baxter International Inc.
  • Braun Melsungen AG
  • Medtronic plc
  • DaVita Inc.
  • Nipro Corporation
  • Terumo Corporation
  • Cook Medical Inc.
  • Allmed Medical Care Holdings Limited
  • CardioMed Supplies Inc.
  • Covidien
  • NxStage Medical Inc.
  • Poly Medicure Limited
  • Asahi Kasei Corporation
  • Bio-Rad Laboratories Inc.
  • Cantel Medical Corporation
  • Hospira Inc.
  • Rockwell Medical
  • Stryker Corporation
  • Toray Medical Co. Ltd.
  • Others

These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.

The India Peritoneal Dialysis Market is segmented as follows:

By Type

  • Hemodialysis
    • Conventional
    • Short Daily Hemodialysis
    • Nocturnal Hemodialysis
  • Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Automated Peritoneal Dialysis (APD)

By Product

  • Device
    • Machine
    • Dialyzers
    • Water Treatment System
    • Others
  • Consumables
    • Bloodlines
    • Concentrates
    • Catheters
    • Others
  • Service

By End-use

  • Home-based
  • Hospital-based

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1 India Peritoneal Dialysis Market, (2024 – 2033) (USD Million)
    • 2.2 India Peritoneal Dialysis Market: snapshot
  • Chapter 3. India Peritoneal Dialysis Market – Industry Analysis
    • 3.1 India Peritoneal Dialysis Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increasing prevalence of end-stage renal disease
      • 3.2.2 Increasing demand for home dialysis treatment
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market Attractiveness Analysis By Type
      • 3.7.2 Market Attractiveness Analysis By Product
  • Chapter 4. India Peritoneal Dialysis Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 India Peritoneal Dialysis Market: company market share, 2023
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, collaboration, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. India Peritoneal Dialysis Market – Type Analysis
    • 5.1 India Peritoneal Dialysis Market Overview: By Type
      • 5.1.1 India Peritoneal Dialysis Market Share, By Type, 2023 and 2033
    • 5.2 Continuous Ambulatory Peritoneal Dialysis
      • 5.2.1 India Peritoneal Dialysis Market by Continuous Ambulatory Peritoneal Dialysis, 2024 – 2033 (USD Million)
    • 5.3 Automated Peritoneal Dialysis
      • 5.3.1 India Peritoneal Dialysis Market by Automated Peritoneal Dialysis, 2024 – 2033 (USD Million)
  • Chapter 6. India Peritoneal Dialysis Market – Product Analysis
    • 6.1 India Peritoneal Dialysis Market Overview: By Product
      • 6.1.1 India Peritoneal Dialysis Market Share, By Product, 2023 and 2033
    • 6.2 Devices (Cyclers/Machines)
      • 6.2.1 India Peritoneal Dialysis Market by Devices (Cyclers/Machines), 2024 – 2033 (USD Million)
    • 6.3 PD Solutions/Fluids
      • 6.3.1 India Peritoneal Dialysis Market by PD Solutions/Fluids, 2024 – 2033 (USD Million)
    • 6.4 PD Sets
      • 6.4.1 India Peritoneal Dialysis Market by PD Sets, 2024 – 2033 (USD Million)
    • 6.5 Catheters
      • 6.5.1 India Peritoneal Dialysis Market by Catheters, 2024 – 2033 (USD Million)
  • Chapter 7. India Peritoneal Dialysis Market – Regional Analysis
    • 7.1 India Peritoneal Dialysis Market Regional Overview
    • 7.2 India Peritoneal Dialysis Market Share, by Region, 2023 & 2033 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1 Fresenius Medical Care
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Baxter International Inc.
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 B. Braun Melsungen AG
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 Medtronic plc
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 DaVita Inc.
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Nipro Corporation
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 Terumo Corporation
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Cook Medical Inc.
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Allmed Medical Care Holdings Limited
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 CardioMed Supplies Inc.
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments
    • 8.11 Covidien
      • 8.11.1 Overview
      • 8.11.2 Financials
      • 8.11.3 Product Portfolio
      • 8.11.4 Business Strategy
      • 8.11.5 Recent Developments
    • 8.12 NxStage Medical Inc.
      • 8.12.1 Overview
      • 8.12.2 Financials
      • 8.12.3 Product Portfolio
      • 8.12.4 Business Strategy
      • 8.12.5 Recent Developments
    • 8.13 Poly Medicure Limited
      • 8.13.1 Overview
      • 8.13.2 Financials
      • 8.13.3 Product Portfolio
      • 8.13.4 Business Strategy
      • 8.13.5 Recent Developments
    • 8.14 Asahi Kasei Corporation
      • 8.14.1 Overview
      • 8.14.2 Financials
      • 8.14.3 Product Portfolio
      • 8.14.4 Business Strategy
      • 8.14.5 Recent Developments
    • 8.15 Bio-Rad Laboratories Inc.
      • 8.15.1 Overview
      • 8.15.2 Financials
      • 8.15.3 Product Portfolio
      • 8.15.4 Business Strategy
      • 8.15.5 Recent Developments
    • 8.16 Cantel Medical Corporation
      • 8.16.1 Overview
      • 8.16.2 Financials
      • 8.16.3 Product Portfolio
      • 8.16.4 Business Strategy
      • 8.16.5 Recent Developments
    • 8.17 Hospira Inc.
      • 8.17.1 Overview
      • 8.17.2 Financials
      • 8.17.3 Product Portfolio
      • 8.17.4 Business Strategy
      • 8.17.5 Recent Developments
    • 8.18 Rockwell Medical
      • 8.18.1 Overview
      • 8.18.2 Financials
      • 8.18.3 Product Portfolio
      • 8.18.4 Business Strategy
      • 8.18.5 Recent Developments
    • 8.19 Stryker Corporation
      • 8.19.1 Overview
      • 8.19.2 Financials
      • 8.19.3 Product Portfolio
      • 8.19.4 Business Strategy
      • 8.19.5 Recent Developments
    • 8.20 Toray Medical Co. Ltd.
      • 8.20.1 Overview
      • 8.20.2 Financials
      • 8.20.3 Product Portfolio
      • 8.20.4 Business Strategy
      • 8.20.5 Recent Developments
    • 8.21 Others.
      • 8.21.1 Overview
      • 8.21.2 Financials
      • 8.21.3 Product Portfolio
      • 8.21.4 Business Strategy
      • 8.21.5 Recent Developments
List Of Figures

Figures No 1 to 15

List Of Tables

Tables No 1 to 2

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2033

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2033
  • Market revenue estimates and forecasts up to 2033, by technology
  • Market revenue estimates and forecasts up to 2033, by application
  • Market revenue estimates and forecasts up to 2033, by type
  • Market revenue estimates and forecasts up to 2033, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Prominent Player

  • Fresenius Medical Care
  • Baxter International Inc.
  • Braun Melsungen AG
  • Medtronic plc
  • DaVita Inc.
  • Nipro Corporation
  • Terumo Corporation
  • Cook Medical Inc.
  • Allmed Medical Care Holdings Limited
  • CardioMed Supplies Inc.
  • Covidien
  • NxStage Medical Inc.
  • Poly Medicure Limited
  • Asahi Kasei Corporation
  • Bio-Rad Laboratories Inc.
  • Cantel Medical Corporation
  • Hospira Inc.
  • Rockwell Medical
  • Stryker Corporation
  • Toray Medical Co. Ltd.
  • Others

FAQs

The restraints of the India Peritoneal Dialysis  market is high cost.

The major driver for the India Peritoneal Dialysis market is increasing prevalence of end-stage renal disease and increasing demand for home dialysis treatment.

The “Continuous Ambulatory Peritoneal Dialysis” category dominated the market in 2023.

The key players in the market are Fresenius Medical Care, Baxter International Inc., B. Braun Melsungen AG, Medtronic plc, DaVita Inc., Nipro Corporation, Terumo Corporation, Cook Medical Inc., Allmed Medical Care Holdings Limited, CardioMed Supplies Inc., Covidien , NxStage Medical Inc., Poly Medicure Limited, Asahi Kasei Corporation, Bio-Rad Laboratories Inc., Cantel Medical Corporation, Hospira Inc., Rockwell Medical, Stryker Corporation, Toray Medical Co. Ltd., Others.

The market is projected to grow at a CAGR of 9.1% during the forecast period, 2024-2033.

The India Peritoneal Dialysis Market size was valued at USD 52.6 Million in 2024.

PURCHASE OPTIONS

$

2890


$

3890


$

4890


$

1890


$

2290

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • Report in your Language.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Report in your Language.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • In-Depth Company Profiles.
  • SWOT Analysis.
  • Identify your Competitors.
  • Recent Development Analysis.
  • Competitor Pricing Strategies.
  • Competitor Marketing Strategies.
  • Competitor Positioning and Messaging.
  • Competitor Product’s Strengths.
  • Free 20% or 10 Hours of Customisation.
  • 15% Discount on your Next Purchase.
  • Upgradable to other licenses.
  • PDF Format.
  • Permission to Print the Report.

Want to customize this report?
100% FREE CUSTOMIZATION!